Drug
Sotatercept-csrk
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Infusion Site Pain | 133 | 44.0 | 45.2 | signal |
| 2 | Pericardial Effusion | 149 | 27.3 | 28.1 | signal |
| 3 | Dyspnoea Exertional | 223 | 25.0 | 26.1 | signal |
| 4 | Epistaxis | 443 | 24.9 | 27.2 | signal |
| 5 | Pain In Jaw | 163 | 24.2 | 25.0 | signal |
| 6 | Complication Associated With Device | 73 | 23.2 | 23.6 | signal |
| 7 | Pulmonary Arterial Hypertension | 72 | 20.8 | 21.1 | signal |
| 8 | Therapy Change | 38 | 16.6 | 16.7 | signal |
| 9 | Pulmonary Hypertension | 81 | 16.3 | 16.5 | signal |
| 10 | Dermatitis Contact | 43 | 15.9 | 16.0 | signal |
| 11 | Decreased Activity | 40 | 15.7 | 15.8 | signal |
| 12 | Seasonal Allergy | 50 | 14.9 | 15.0 | signal |
| 13 | Weight Fluctuation | 30 | 12.1 | 12.1 | signal |
| 14 | Dizziness Postural | 26 | 11.4 | 11.4 | signal |
| 15 | Oxygen Saturation Decreased | 150 | 11.3 | 11.6 | signal |
| 16 | Device Occlusion | 37 | 11.2 | 11.2 | signal |
| 17 | Gingival Bleeding | 31 | 9.5 | 9.6 | signal |
| 18 | Fluid Retention | 110 | 9.1 | 9.3 | signal |
| 19 | Blood Test Abnormal | 30 | 9.0 | 9.0 | signal |
| 20 | Haemoptysis | 54 | 8.1 | 8.2 | signal |
| 21 | Laboratory Test Abnormal | 56 | 8.0 | 8.0 | signal |
| 22 | Internal Haemorrhage | 21 | 7.7 | 7.7 | signal |
| 23 | Therapy Non-responder | 80 | 7.5 | 7.6 | signal |
| 24 | Brain Fog | 23 | 6.6 | 6.6 | signal |
| 25 | Therapy Partial Responder | 23 | 6.4 | 6.4 | signal |
| 26 | Blood Iron Decreased | 18 | 6.4 | 6.4 | signal |
| 27 | Therapy Interrupted | 104 | 6.3 | 6.4 | signal |
| 28 | Product Prescribing Issue | 30 | 6.2 | 6.2 | signal |
| 29 | Flushing | 147 | 6.0 | 6.2 | signal |
| 30 | Hypoxia | 50 | 6.0 | 6.0 | signal |
| 31 | Device Leakage | 59 | 5.8 | 5.9 | signal |
| 32 | Syringe Issue | 23 | 5.5 | 5.5 | signal |
| 33 | Device Dislocation | 56 | 5.4 | 5.5 | signal |
| 34 | Sinus Congestion | 17 | 5.3 | 5.3 | signal |
| 35 | Nasal Congestion | 73 | 5.2 | 5.3 | signal |
| 36 | Gastrointestinal Haemorrhage | 104 | 5.2 | 5.3 | signal |
| 37 | Iron Deficiency Anaemia | 11 | 5.0 | 5.0 | signal |
| 38 | Ear Discomfort | 12 | 4.9 | 4.9 | signal |
| 39 | Platelet Count Decreased | 123 | 4.8 | 4.9 | signal |
| 40 | Injection Site Irritation | 14 | 4.6 | 4.6 | signal |
| 41 | Head Discomfort | 19 | 4.5 | 4.5 | signal |
| 42 | Appendicitis | 10 | 4.5 | 4.5 | signal |
| 43 | Peripheral Swelling | 165 | 4.5 | 4.6 | signal |
| 44 | Presyncope | 26 | 4.5 | 4.5 | signal |
| 45 | Headache | 668 | 4.5 | 5.0 | signal |
| 46 | Exposure Via Skin Contact | 23 | 4.3 | 4.3 | signal |
| 47 | Hospice Care | 10 | 4.3 | 4.3 | signal |
| 48 | Device Related Infection | 15 | 4.1 | 4.1 | signal |
| 49 | Hospitalisation | 148 | 4.1 | 4.2 | signal |
| 50 | Dyspnoea | 544 | 4.0 | 4.4 | signal |
| 51 | Blood Pressure Abnormal | 19 | 4.0 | 4.0 | signal |
| 52 | Hypotension | 191 | 4.0 | 4.1 | signal |
| 53 | Respiratory Tract Congestion | 15 | 3.9 | 4.0 | signal |
| 54 | Syncope | 94 | 3.9 | 4.0 | signal |
| 55 | Blood Pressure Decreased | 62 | 3.9 | 4.0 | signal |
| 56 | Skin Laceration | 10 | 3.9 | 3.9 | signal |
| 57 | Throat Irritation | 40 | 3.7 | 3.8 | signal |
| 58 | Productive Cough | 42 | 3.7 | 3.7 | signal |
| 59 | Intentional Dose Omission | 24 | 3.7 | 3.7 | signal |
| 60 | Product Preparation Error | 18 | 3.6 | 3.6 | signal |
| 61 | Rectal Haemorrhage | 37 | 3.6 | 3.6 | signal |
| 62 | Chest Pain | 159 | 3.6 | 3.7 | signal |
| 63 | Illness | 86 | 3.6 | 3.6 | signal |
| 64 | Sputum Discoloured | 8 | 3.5 | 3.5 | signal |
| 65 | Therapy Cessation | 43 | 3.5 | 3.5 | signal |
| 66 | Acute Respiratory Failure | 16 | 3.5 | 3.5 | signal |
| 67 | Migraine | 79 | 3.5 | 3.5 | signal |
| 68 | Oedema | 45 | 3.5 | 3.5 | signal |
| 69 | Gastrointestinal Pain | 9 | 3.4 | 3.4 | signal |
| 70 | Diarrhoea | 521 | 3.4 | 3.7 | signal |
| 71 | Malnutrition | 9 | 3.4 | 3.4 | signal |
| 72 | Oedema Peripheral | 99 | 3.4 | 3.4 | signal |
| 73 | Dizziness | 402 | 3.4 | 3.6 | signal |
| 74 | Skin Infection | 9 | 3.4 | 3.4 | signal |
| 75 | Injection Site Rash | 24 | 3.3 | 3.3 | signal |
| 76 | No Adverse Event | 140 | 3.3 | 3.4 | signal |
| 77 | Haemoglobin Decreased | 81 | 3.3 | 3.3 | signal |
| 78 | Gastric Haemorrhage | 9 | 3.3 | 3.3 | signal |
| 79 | Scratch | 8 | 3.2 | 3.2 | signal |
| 80 | Platelet Count Increased | 10 | 3.2 | 3.2 | signal |
| 81 | Renal Pain | 8 | 3.2 | 3.2 | signal |
| 82 | Eye Haemorrhage | 10 | 3.1 | 3.1 | signal |
| 83 | Device Issue | 65 | 3.1 | 3.1 | signal |
| 84 | Gout | 13 | 3.0 | 3.0 | signal |
| 85 | Sinus Disorder | 14 | 3.0 | 3.0 | signal |
| 86 | Product Dose Omission Issue | 200 | 2.9 | 3.0 | signal |
| 87 | Sciatica | 11 | 2.9 | 2.9 | signal |
| 88 | Cough | 194 | 2.9 | 3.0 | signal |
| 89 | Clostridium Difficile Infection | 15 | 2.9 | 2.9 | signal |
| 90 | Haematochezia | 38 | 2.9 | 2.9 | signal |
| 91 | Sluggishness | 7 | 2.9 | 2.9 | signal |
| 92 | Unintentional Medical Device Removal | 8 | 2.9 | 2.9 | signal |
| 93 | Ascites | 20 | 2.8 | 2.9 | signal |
| 94 | General Physical Health Deterioration | 77 | 2.8 | 2.8 | signal |
| 95 | Full Blood Count Abnormal | 7 | 2.8 | 2.8 | signal |
| 96 | Weight Decreased | 183 | 2.7 | 2.8 | signal |
| 97 | Increased Tendency To Bruise | 6 | 2.7 | 2.7 | signal |
| 98 | Device Use Error | 22 | 2.7 | 2.7 | signal |
| 99 | Pulmonary Thrombosis | 7 | 2.7 | 2.7 | signal |
| 100 | Injection Site Nodule | 7 | 2.7 | 2.7 | signal |
| 101 | Heart Rate Increased | 63 | 2.7 | 2.7 | signal |
| 102 | Device Use Issue | 11 | 2.7 | 2.7 | signal |
| 103 | Cyanosis | 10 | 2.7 | 2.7 | signal |
| 104 | Pain In Extremity | 187 | 2.7 | 2.7 | signal |
| 105 | Pneumothorax | 10 | 2.6 | 2.6 | signal |
| 106 | Cardiogenic Shock | 9 | 2.6 | 2.6 | signal |
| 107 | Subdural Haematoma | 9 | 2.6 | 2.6 | signal |
| 108 | Skin Haemorrhage | 9 | 2.6 | 2.6 | signal |
| 109 | Dyspepsia | 60 | 2.6 | 2.6 | signal |
| 110 | Insurance Issue | 9 | 2.5 | 2.5 | signal |
| 111 | Pulmonary Oedema | 27 | 2.5 | 2.5 | signal |
| 112 | Injection Site Pruritus | 40 | 2.5 | 2.5 | signal |
| 113 | Faeces Discoloured | 13 | 2.5 | 2.5 | signal |
| 114 | Blood Potassium Decreased | 18 | 2.5 | 2.5 | signal |
| 115 | Hypersomnia | 17 | 2.5 | 2.5 | signal |
| 116 | Haemorrhage | 62 | 2.5 | 2.5 | signal |
| 117 | Dry Throat | 6 | 2.5 | 2.5 | no signal |
| 118 | Weight Increased | 131 | 2.5 | 2.5 | signal |
| 119 | Subarachnoid Haemorrhage | 6 | 2.5 | 2.5 | no signal |
| 120 | Injection Site Bruising | 46 | 2.4 | 2.5 | signal |
| 121 | Product Use Complaint | 9 | 2.4 | 2.4 | signal |
| 122 | Injection Site Erythema | 71 | 2.4 | 2.4 | signal |
| 123 | Heart Rate Decreased | 20 | 2.4 | 2.4 | signal |
| 124 | Secretion Discharge | 7 | 2.4 | 2.4 | signal |
| 125 | Joint Swelling | 68 | 2.4 | 2.4 | signal |
| 126 | Pharyngitis Streptococcal | 6 | 2.3 | 2.3 | no signal |
| 127 | Ocular Discomfort | 6 | 2.3 | 2.3 | no signal |
| 128 | Mood Altered | 15 | 2.3 | 2.3 | signal |
| 129 | Device Malfunction | 37 | 2.3 | 2.3 | signal |
| 130 | Inappropriate Schedule Of Product Administration | 97 | 2.3 | 2.3 | signal |
| 131 | Rash Macular | 19 | 2.3 | 2.3 | signal |
| 132 | Influenza | 61 | 2.3 | 2.3 | signal |
| 133 | Nerve Injury | 6 | 2.3 | 2.3 | no signal |
| 134 | Rash Pruritic | 29 | 2.3 | 2.3 | signal |
| 135 | Systemic Lupus Erythematosus | 19 | 2.2 | 2.3 | signal |
| 136 | Fatigue | 416 | 2.2 | 2.4 | signal |
| 137 | Incorrect Route Of Product Administration | 9 | 2.2 | 2.2 | signal |
| 138 | Respiratory Disorder | 16 | 2.2 | 2.2 | signal |
| 139 | Chest Discomfort | 54 | 2.2 | 2.2 | signal |
| 140 | Abdominal Discomfort | 88 | 2.2 | 2.2 | signal |
| 141 | Blood Urine Present | 10 | 2.2 | 2.2 | signal |
| 142 | Limb Injury | 14 | 2.2 | 2.2 | signal |
| 143 | Post Procedural Haemorrhage | 6 | 2.2 | 2.2 | no signal |
| 144 | Nausea | 404 | 2.1 | 2.2 | signal |
| 145 | Viral Infection | 17 | 2.1 | 2.1 | signal |
| 146 | Contusion | 49 | 2.1 | 2.1 | signal |
| 147 | Carpal Tunnel Syndrome | 7 | 2.1 | 2.1 | no signal |
| 148 | Localised Infection | 12 | 2.1 | 2.1 | signal |
| 149 | Sneezing | 11 | 2.1 | 2.1 | signal |
| 150 | Gastrointestinal Disorder | 43 | 2.0 | 2.0 | signal |
| 151 | Abnormal Weight Gain | 6 | 2.0 | 2.0 | no signal |
| 152 | Increased Appetite | 9 | 2.0 | 2.0 | no signal |
| 153 | Palpitations | 55 | 2.0 | 2.0 | no signal |
| 154 | Blood Pressure Fluctuation | 11 | 1.9 | 1.9 | no signal |
| 155 | Melaena | 10 | 1.9 | 1.9 | no signal |
| 156 | Cardiac Disorder | 42 | 1.9 | 1.9 | no signal |
| 157 | Gallbladder Disorder | 8 | 1.9 | 1.9 | no signal |
| 158 | Eye Infection | 5 | 1.9 | 1.9 | no signal |
| 159 | Head Injury | 14 | 1.9 | 1.9 | no signal |
| 160 | Hypoacusis | 19 | 1.9 | 1.9 | no signal |
| 161 | Heart Rate Irregular | 10 | 1.8 | 1.8 | no signal |
| 162 | Injection Site Warmth | 9 | 1.8 | 1.8 | no signal |
| 163 | Product Use Issue | 81 | 1.8 | 1.8 | no signal |
| 164 | Eye Swelling | 16 | 1.8 | 1.8 | no signal |
| 165 | Device Breakage | 17 | 1.8 | 1.8 | no signal |
| 166 | Aphonia | 6 | 1.8 | 1.8 | no signal |
| 167 | Diarrhoea Haemorrhagic | 4 | 1.8 | 1.8 | no signal |
| 168 | Drug Effect Less Than Expected | 6 | 1.8 | 1.8 | no signal |
| 169 | Injection Site Swelling | 32 | 1.8 | 1.8 | no signal |
| 170 | Amenorrhoea | 7 | 1.8 | 1.8 | no signal |
| 171 | Cardiac Failure | 33 | 1.7 | 1.7 | no signal |
| 172 | Dermatitis Allergic | 5 | 1.7 | 1.7 | no signal |
| 173 | Feeling Abnormal | 95 | 1.7 | 1.7 | no signal |
| 174 | Erythema | 81 | 1.7 | 1.7 | no signal |
| 175 | Device Adhesion Issue | 6 | 1.7 | 1.7 | no signal |
| 176 | Wrong Technique In Device Usage Process | 18 | 1.6 | 1.7 | no signal |
| 177 | Device Difficult To Use | 26 | 1.6 | 1.7 | no signal |
| 178 | Cerebral Haemorrhage | 14 | 1.6 | 1.6 | no signal |
| 179 | Thyroid Disorder | 6 | 1.6 | 1.6 | no signal |
| 180 | Adverse Drug Reaction | 34 | 1.6 | 1.6 | no signal |
| 181 | Injection Site Pain | 114 | 1.6 | 1.6 | no signal |
| 182 | Hunger | 5 | 1.6 | 1.6 | no signal |
| 183 | Pericarditis | 6 | 1.5 | 1.5 | no signal |
| 184 | Adverse Event | 32 | 1.5 | 1.5 | no signal |
| 185 | Full Blood Count Decreased | 7 | 1.5 | 1.5 | no signal |
| 186 | Hot Flush | 26 | 1.4 | 1.4 | no signal |
| 187 | Injection Site Haemorrhage | 27 | 1.4 | 1.4 | no signal |
| 188 | Product Dose Omission In Error | 9 | 1.4 | 1.4 | no signal |
| 189 | Haemorrhage Intracranial | 5 | 1.4 | 1.4 | no signal |
| 190 | Product Physical Issue | 6 | 1.3 | 1.3 | no signal |
| 191 | Injection Site Discomfort | 3 | 1.2 | 1.2 | no signal |
| 192 | Coronary Artery Occlusion | 4 | 1.2 | 1.2 | no signal |
| 193 | Needle Issue | 8 | 1.2 | 1.2 | no signal |
| 194 | Incorrect Dose Administered | 56 | 1.0 | 1.0 | no signal |
| 195 | Injection Site Mass | 9 | 1.0 | 1.0 | no signal |
| 196 | Skin Irritation | 11 | 1.0 | 1.0 | no signal |
| 197 | Poisoning | 3 | 1.0 | 1.0 | no signal |
| 198 | Acne | 18 | 1.0 | 1.0 | no signal |
| 199 | Accidental Exposure To Product | 23 | 1.0 | 1.0 | no signal |
| 200 | Device Delivery System Issue | 6 | 1.0 | 1.0 | no signal |
| 201 | Application Site Rash | 3 | 0.9 | 0.9 | no signal |
| 202 | Device Failure | 3 | 0.8 | 0.8 | no signal |
| 203 | Product Storage Error | 16 | 0.8 | 0.8 | no signal |
| 204 | Application Site Pain | 4 | 0.8 | 0.8 | no signal |
| 205 | Application Site Pruritus | 4 | 0.7 | 0.7 | no signal |
| 206 | Extra Dose Administered | 7 | 0.7 | 0.7 | no signal |
| 207 | Injection Site Urticaria | 4 | 0.7 | 0.7 | no signal |
| 208 | Vaginal Haemorrhage | 7 | 0.7 | 0.7 | no signal |
| 209 | Therapeutic Response Shortened | 5 | 0.7 | 0.7 | no signal |
| 210 | Application Site Erythema | 4 | 0.6 | 0.6 | no signal |
| 211 | Injury Associated With Device | 3 | 0.6 | 0.6 | no signal |
| 212 | Skin Burning Sensation | 10 | 0.6 | 0.6 | no signal |
| 213 | Incorrect Dose Administered By Device | 3 | 0.5 | 0.5 | no signal |
| 214 | Drug Dose Omission By Device | 3 | 0.2 | 0.2 | no signal |